Population Pharmacokinetic (PK) Study of Multiple Doses of Cubicin® (Daptomycin) 10 mg/kg in Critical Care Patients Having Bacteremia, Endocarditis or Skin Soft Tissue Infections Due to Gram Positive Bacteria With Various Degrees of Renal Failure

Clinical trial NCT02142075 · COMPLETED

Trial details

NCT number: NCT02142075
Sponsor: Poitiers University Hospital
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Renal Failure Critical Care Gram Positive Bacteria

Start date: 2014-03-01
Primary completion: 2015-09-01

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.